share_log

Bernstein Maintains Outperform on Guardant Health, Lowers Price Target to $35

Benzinga ·  Oct 31 05:56  · Ratings

Bernstein analyst Eve Burstein maintains Guardant Health (NASDAQ:GH) with a Outperform and lowers the price target from $40 to $35.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment